Jing Peng

This publication record appears to combine several distinct lines of work, including molecular studies of colorectal cancer cell death and protein degradation pathways (such as translocon-associated proteins and ER-associated degradation), liver surgery outcomes, and broader clinical topics like COVID-19, nutrition, and pregnancy-related health. Prospective students should note that the diversity of topics suggests this name may be associated with multiple contributing authors or collaborative teams rather than a single tightly focused research program. The work generally involves laboratory cell biology techniques alongside clinical and epidemiological research methods.

Publication output has grown over the last decade, rising from about 1-2 papers per year in 2017-2019 to a peak of around 6-8 papers per year in 2021 and 2023-2025, despite an apparent gap in 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026